Hepatitis C Virus (HCV) Treatment Completion or Withdrawal

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Department of Veterans Affairs
ClinicalTrials.gov Identifier:
NCT00674492
First received: May 6, 2008
Last updated: April 23, 2012
Last verified: October 2008

May 6, 2008
April 23, 2012
May 2008
August 2008   (final data collection date for primary outcome measure)
Attributes of treatment experience identified in inductive qualitative analysis [ Time Frame: Zero to five years since ending treatment. ] [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT00674492 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Hepatitis C Virus (HCV) Treatment Completion or Withdrawal
Patients' View of Hepatitis C Treatment Completion or Withdrawal

Qualitative pilot study of patients' views of their experience with antiviral treatment for hepatitis C.

Qualitative pilot study of patient' views of their experiences with antiviral treatment for hepatitis C. Two groups of patients will be sampled: nine who completed a 24 or 48 week course of treatment and nine who withdrew from treatment prior to planned end. Interview data will be analyzed using narrative and grounded theory methods to identify attributes of treatment experience that may discriminate between completion and withdrawal.

Observational
Time Perspective: Retrospective
Not Provided
Not Provided
Non-Probability Sample

VHA patients who ever initiated antiviral treatment for hepatitis C.

Hepatitis C
Not Provided
Group 1
patients who initiated antiviral treatment for hepatitis C
Groessl EJ, Weingart KR, Kaplan RM, Clark JA, Gifford AL, Ho SB. Living with hepatitis C: qualitative interviews with hepatitis C-infected veterans. J Gen Intern Med. 2008 Dec;23(12):1959-65. Epub 2008 Sep 20.

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
18
August 2008
August 2008   (final data collection date for primary outcome measure)

Inclusion Criteria:

Ever initiated anitiviral treatment for hepatitis C.

Exclusion Criteria:

none

Both
18 Years and older
No
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT00674492
SHP 08-193
No
Department of Veterans Affairs
Department of Veterans Affairs
Not Provided
Principal Investigator: Jack A Clark, PhD VA New England Health Care System
Department of Veterans Affairs
October 2008

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP